Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Childrens Cancer Group 8891 (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup StudyPediatric Oncology Group 9048 and Childrens Cancer Group 8891
In stock Product Specifications: CAS Number: Blend of Ipamorelin (170851-70-4) and CJC-1295 No DAC (863288-34-0) Molecular Formula: Ipamorelin: CHNO CJC-1295 No DAC: CHNO Molecular Weight: Ipamorelin: ~711.86 g/mol CJC-1295 No DAC: ~3647.04 g/mol Quantity: 5mg Ipamorelin + 5mg CJC-1295 per vial (lyophilized powder) Purity: 99% (HPLC verified) Form: Sterile, freeze-dried powder Storage: Store lyophilized peptide at 20 C (or 28 C short-term)
Medicina-Lithuania (2021) 57(10):1030
[DOI] [PMC free article] [PubMed] [Google Scholar] 162.Townsend J.R., Kirby T.O., Marshall T.M., Church D.D., Jajtner A.R., Esposito R
J Ethnopharmacol 235:164182
A significant portion are people who play tennis or golf recreationally and have been dealing with tendon tears or chronic overuse injuries for months